HER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in Russia

计划入组 774 人 · 首次发布于 2023 年 6 月 15 日

Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea

计划入组 1,695 人 · 首次发布于 2015 年 9 月 2 日

Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast Cancer

计划入组 26 人 · 首次发布于 2011 年 3 月 29 日

DF-1001

ado-trastuzumab emtansine(Herceptin, Herceptin Hylecta, Herzuma, Kanjinti, Ontruzant, Perjeta-Herceptin, Phesgo, Trazimera, Herwenda, Ogivri, Zercepac, Tuznue, Dazublys)

Rx

epidermal growth factor

Zymeworks

Canada

Veru Inc

United States

Arvinas Estrogen Receptor, Inc.

United States

Roche's Itovebi Demonstrates Overall Survival Benefit in PIK3CA-Mutated Breast Cancer

Genor Biopharma Secures NMPA Approval for Lerociclib CDK4/6 Inhibitor in Advanced Breast Cancer

Roche's Itovebi Plus Palbociclib and Fulvestrant Significantly Improves Progression-Free Survival in PIK3CA-Mutated Breast Cancer